GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2
WEB1 day ago · GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
WEB2 days ago · GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court cases alleging that its old reflux medication Zantac was contaminated with ...
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
WEB1 day ago · GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion. By Rebecca Robbins The British drug maker GSK said on Wednesday that it ...
Pharma giant GSK to pay $2.2 to settle Zantac lawsuits - BBC
WEB1 day ago · UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.
British pharma giant GSK strikes $2.3 billion deal to put an end to ...
WEB1 day ago · British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
WEB1 day ago · GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court cases alleging that its old reflux medication Zantac was contaminated with a suspected carcinogen.. The cases represent about 93% of those against the company involving Zantac, GSK said Wednesday in a …
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln
WEB2 days ago · GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
WEB2 days ago · GSK agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine Zantac causes cancer.
Statement: Zantac (ranitidine) litigation – settlement agreements ...
WEB2 days ago · GSK to resolve 93% (approximately 80,000 cases) of U.S. state court Zantac product liability cases for up to $2.2 billion; Separate settlement of qui tam complaint for $70 million; Settlements agreed with no admission of liability; No change to GSK’s growth agenda or investment plans;
Zantac maker GSK agrees to pay $2.3 bn in US settlements
WEB2 days ago · British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.
- Some results have been removed